Progress in Molecular Biology and Translational Science
Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B
Series: Progress in Molecular Biology and Translational Science; 163;
- Publisher's listprice EUR 122.00
-
47 653 Ft (45 384 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 4 765 Ft off)
- Discounted price 42 888 Ft (40 846 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
47 653 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 26 April 2019
- ISBN 9780128177402
- Binding Hardback
- No. of pages551 pages
- Size 229x152 mm
- Weight 970 g
- Language English 0
Categories
Long description:
Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases-30 Years Clinical Applications in China, and more.
MoreTable of Contents:
1. An Overview of Fugal Glycan-based Therapeutics
Dandan Yang
2. Heparin: An Essential Drug for Modern Medicine
Cui Hao
3. Low Molecular Weight Heparins and Their Clinical Applications
Cui Hao
4. The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharide
Yiran Zhang
5. Heparinoids as Clinically Used Drugs
Huaiqian Dou
6. Marine Glycan-Derived Therapeutics in China
Yanyun Gao
7. Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases--30 Years Clinical Applications in China
Ming Shan
8. Ganoderma Sinense Polysaccharide--An Adjunctive Drug Used for Cancer Treatment
Meng Zhang
9. Fucoidan Used for Treating Renal Diseases: A Review of 15 Years Clinical Studies
Jing Wang
10. Ganoderma Lucidum Polysaccharide Used for Treating Physical Frailty in China
Pengjiao Zeng
11. The Biological Activities of the Antitumor Drug Grifola Frondosa Polysaccharide
Yanli He
12. Molecular Basis for Poria cocos Mushroom Polysaccharide Used as an Antitumor Drug in China
Xiulian Li
13. Biological Mechanisms of Glycan- and Glycosaminoglycan-based Nutraceuticals
Yang Tang
14. Mushroom Polysaccharide Lentinan for Treating Different Types of Cancers-A Review of 12 Years of Clinical Studies in China
Yiran Zhang
15. Polyporus Umbellatus Polysaccharide in Treating Hepatitis B in China
Zhihua Guo
16. Coriolus Versicolor Polysaccharopeptide as an Immunotherapeutic in China
Huaiqian Dou
17. Tremella Polysaccharide: The molecular Mechanisms of its Drug Action
Dandan Yang
18. The Structures and Biological Functions of Polysaccharides from Traditional Chinese Herbs
Pengjiao Zeng
